nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—Olanzapine—ADRA1B—polycystic ovary syndrome	0.0106	0.146	CrCbGaD
Pirenzepine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.00971	0.134	CrCbGaD
Pirenzepine—Mirtazapine—ADRA1A—polycystic ovary syndrome	0.00757	0.104	CrCbGaD
Pirenzepine—Olanzapine—ADRA1A—polycystic ovary syndrome	0.00711	0.098	CrCbGaD
Pirenzepine—Loxapine—ADRA1B—polycystic ovary syndrome	0.00656	0.0905	CrCbGaD
Pirenzepine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.00654	0.0902	CrCbGaD
Pirenzepine—Clozapine—ADRA1B—polycystic ovary syndrome	0.00551	0.076	CrCbGaD
Pirenzepine—Mirtazapine—ADRB2—polycystic ovary syndrome	0.0045	0.0621	CrCbGaD
Pirenzepine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.00445	0.0613	CrCbGaD
Pirenzepine—Loxapine—ADRA1A—polycystic ovary syndrome	0.00442	0.0609	CrCbGaD
Pirenzepine—Clozapine—ADRA1A—polycystic ovary syndrome	0.00371	0.0511	CrCbGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00293	0.00316	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00288	0.00311	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.00288	0.00311	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00285	0.00307	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00278	0.003	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00277	0.00299	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00277	0.00298	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00272	0.00293	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00268	0.00289	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00261	0.00282	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00261	0.00282	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00258	0.00278	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00251	0.00271	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00251	0.00271	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00248	0.00268	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00244	0.00264	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00243	0.00262	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00239	0.00258	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00237	0.00256	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00236	0.00255	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00231	0.00249	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00231	0.00249	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.0023	0.00248	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00228	0.00246	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00228	0.00246	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00227	0.00245	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00223	0.0024	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00223	0.0024	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00221	0.00239	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00221	0.00238	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00221	0.00238	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00219	0.00236	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00218	0.00235	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00216	0.00233	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00214	0.0023	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00211	0.00228	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0021	0.00226	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0021	0.00226	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00206	0.00223	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00206	0.00222	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00205	0.00221	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00201	0.00216	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00199	0.00215	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00198	0.00213	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00196	0.00212	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00195	0.00211	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00195	0.0021	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00193	0.00208	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00191	0.00206	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0019	0.00205	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0019	0.00205	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.0019	0.00205	CbGpPWpGaD
Pirenzepine—Clozapine—CYP1A1—polycystic ovary syndrome	0.00189	0.0261	CrCbGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00185	0.002	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00181	0.00195	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00178	0.00192	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00177	0.00191	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00175	0.00189	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00173	0.00186	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.0017	0.00183	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00169	0.00182	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00168	0.00182	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00168	0.00181	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00166	0.00179	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00163	0.00175	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00161	0.00173	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.0016	0.00173	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00157	0.00169	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00157	0.00169	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00156	0.00168	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00156	0.00168	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00154	0.00166	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00154	0.00166	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00153	0.00165	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.0015	0.00162	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00149	0.0016	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00148	0.00159	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00148	0.00159	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00145	0.00157	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00144	0.00156	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.0014	0.00151	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00139	0.0015	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00139	0.0015	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00138	0.00149	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00135	0.00146	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NPB—polycystic ovary syndrome	0.00135	0.00145	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00134	0.00145	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00134	0.00145	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00134	0.00145	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00134	0.00144	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00131	0.00141	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.0013	0.00141	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00129	0.00139	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00128	0.00137	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00125	0.00135	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00125	0.00135	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00124	0.00133	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00123	0.00132	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00122	0.00131	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00122	0.00131	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00121	0.00131	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.0012	0.00129	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00119	0.00129	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00119	0.00129	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00119	0.00128	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00119	0.00128	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00118	0.00128	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00114	0.00123	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00113	0.00121	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00113	0.00121	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.0011	0.00118	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00109	0.00117	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00108	0.00117	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00108	0.00117	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00108	0.00116	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00108	0.00116	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00106	0.00114	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00105	0.00113	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00102	0.0011	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000994	0.00107	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000989	0.00107	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000982	0.00106	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000971	0.00105	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000969	0.00104	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000952	0.00103	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000949	0.00102	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00094	0.00101	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000919	0.000991	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000909	0.000981	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000904	0.000975	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000898	0.000968	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000882	0.000951	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000881	0.00095	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000864	0.000932	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000859	0.000926	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000854	0.000921	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000843	0.000909	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000841	0.000906	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000835	0.0009	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000824	0.000888	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000806	0.000869	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000801	0.000863	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.0008	0.000863	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000792	0.000854	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000792	0.000854	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000774	0.000835	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000763	0.000823	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000753	0.000812	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000746	0.000804	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000741	0.000799	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FST—polycystic ovary syndrome	0.000734	0.000791	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00073	0.000787	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000725	0.000782	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000719	0.000776	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LHB—polycystic ovary syndrome	0.000717	0.000773	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.0007	0.000755	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.0007	0.000755	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000682	0.000735	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000678	0.000731	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000677	0.00073	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SCT—polycystic ovary syndrome	0.000671	0.000724	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000663	0.000715	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000641	0.000691	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000637	0.000687	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000629	0.000679	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000624	0.000673	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000621	0.00067	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000621	0.000669	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000615	0.000663	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000583	0.000628	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00058	0.000625	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000575	0.00062	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000568	0.000612	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000564	0.000608	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.00055	0.000593	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000545	0.000588	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00053	0.000572	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000522	0.000563	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000517	0.000557	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000514	0.000554	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000514	0.000554	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000511	0.00055	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000509	0.000549	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000505	0.000544	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000493	0.000532	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000478	0.000515	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000477	0.000514	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000473	0.00051	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000473	0.00051	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000473	0.00051	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000467	0.000503	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000462	0.000498	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000456	0.000491	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000451	0.000487	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000451	0.000486	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000443	0.000478	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00044	0.000474	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000439	0.000474	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000438	0.000472	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000438	0.000472	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000433	0.000467	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000416	0.000449	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000414	0.000446	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000413	0.000445	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00041	0.000442	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000405	0.000436	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000398	0.000429	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000392	0.000422	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000387	0.000417	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000368	0.000396	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000363	0.000391	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000362	0.00039	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000358	0.000386	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000346	0.000373	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00034	0.000366	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000333	0.000359	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000333	0.000359	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000321	0.000346	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000318	0.000343	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00031	0.000334	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000308	0.000333	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000293	0.000316	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000291	0.000314	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000291	0.000314	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000291	0.000313	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000285	0.000307	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00028	0.000302	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000276	0.000297	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000256	0.000276	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000254	0.000274	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	0.000244	0.000264	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000244	0.000263	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	0.000243	0.000262	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000239	0.000258	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000235	0.000254	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000235	0.000253	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000223	0.000241	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000205	0.000221	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.0002	0.000216	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	0.00018	0.000194	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000179	0.000193	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000172	0.000186	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000171	0.000185	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000166	0.000179	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000165	0.000178	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000157	0.00017	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000154	0.000166	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000127	0.000137	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000108	0.000117	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	0.000106	0.000115	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	7.48e-05	8.06e-05	CbGpPWpGaD
